Tue, Sep 16, 2014, 4:55 AM EDT - U.S. Markets open in 4 hrs 35 mins

Recent

% | $
Quotes you view appear here for quick access.

Centerline Holding Co. Message Board

  • frank100_20012002 frank100_20012002 May 2, 2004 1:16 PM Flag

    This is the problem Part 1.

    Basically the problem is this: Borrowing short and lending long can reduce your cash flow when interest rates rise. So any assumption that the present yield will never be reduced, or any assumption that the current yield will stay the same and put a floor under the price of the stock, is not a valid assumption.

    If you go to chartermac.com and request an annual report, CHC will promptly send you the 10k for the fiscal year ending 12/31/03. Under "We may suffer adverse consequences from changes in interest rates" on Page 11, it reads: "Since a significant portion of our investments represent residual interests in revenue bonds or other securities whose cash flow is first used to pay senior securities with short-term floating interest rates, any increase in short-term interest rates will increase the amount of interest we are required to pay on the senior securities and reduce the cash flow from out residual interests. Any significant increase in short term interest rates could adversely affect the market value of our shares by reducing the amount of cash available for distribution to our shareholders."

    This is not the end of the world; but you should be fully aware of the risk you are taking by holding onto the stock. My bet is that the conference call on May 5 will be positive and the shares will move up. If they do move up, it would be a good time, in my opinion, to make up your mind if you want to hold or fold. I'll give more info on this in Part 2. Gotta go.

 

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Avanir Pharmaceuticals, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT
21Vianet Group, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT